S&P 500 7,580.07 −1.82%
Nasdaq 25,437.00 −2.86%
S&P/TSX 35,620.03 −1.74%
Apple 344.63 −1.23%
Nvidia 204.64 −4.22%
Microsoft 521.91 −1.55%
Shopify 220.37 −5.70%
Royal Bank 283.93 −1.49%
CAD/USD 0.7157 +0.10%
CLOSED · 01:40 ET
Market ClerkRecap
Sat Oct 31 · markets closed3 signals on Oct 30129 insider buys this week · $10BCIRO short report next: Nov 14The week ahead
HJ
INSIDER · RAPP · Rapport Therapeutics, Inc. · DIRECTOR

HEALY JAMES

Every open-market transaction filed under this name, Oct 28 to Oct 28.

Filings
4
4 buys · 0 sells
Bought
$20.4M
open market, at cost
Sold
—
includes scheduled sales
Buys since
+15.3%
avg move from buy price, 4 priced

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 28RAPPRapport Therapeutics, Inc.DirectorBuy6,933$21.00$146K+15.3%
Oct 28RAPPRapport Therapeutics, Inc.DirectorBuy3,772$21.00$79K+15.3%
Oct 28RAPPRapport Therapeutics, Inc.DirectorBuy6,395$21.00$134K+15.3%
Oct 28RAPPRapport Therapeutics, Inc.DirectorBuy952,380$21.00$20M+15.3%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.